Price Performance
- Day's Low
- ₹268.13
- Day's High
- ₹286.4
₹ 278.8
- 52-w low
- ₹112.35
- 52-w high
- ₹286.4
278.8
- Day's open
₹280 - Previous close
₹270.51001 - VWAP
₹279.55 - Lower price band
₹243.45 - Upper price band
₹297.56
Today's Market Action
The last traded share price of Panacea Biotec Ltd was 278.80 up by 3.06% on the NSE. Its last traded stock price on BSE was 278.25 up by 2.83%. The total volume of shares on NSE and BSE combined was 1,628,219 shares. Its total combined turnover was Rs 45.52 crores.
Medium and Long Term Market Action
Panacea Biotec Ltd hit a 52-week high of 286.4 on 10-09-2024 and a 52-week low of 112.35 on 04-06-2024.
The stock price of Panacea Biotec Ltd is up by 102% over the last one month. It is up by 107.29% over the last one year. Don't forget to check the full stock price history in the table below.
Fundamentals
-
Market Cap (Cr): 1657
-
Book Value (₹):
-
Stock P/E:
-
Revenue (Cr):
-
Total Debt (Cr):
-
Face Value (₹):
-
Roce (%):
-
ROE (%):
-
Earnings (Cr):
-
Promoter’s Holdings (%):
-
EPS (₹):
-
Debt to Equity:
-
Dividend Yield (%):
-
Cash (Cr):
Mutual fund holdings and trends
FUND NAME | Quantity | Monthly Change (Qty) |
---|
Similar Stocks
Company | Price | Market Cap (Cr) | P/E |
---|
About
Data not available.
FAQ's
What is Share Price of Panacea Biotec Ltd?
What is the Market Cap of Panacea Biotec Ltd?
What is PE Ratio of Panacea Biotec Ltd?
What is PB Ratio of Panacea Biotec Ltd?
What is the CAGR of Panacea Biotec Ltd?
How to Buy Panacea Biotec Ltd Share?
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
Consolidated Financial Performace In Graph(Net Profit)
Standalone Financial Performace In Graph(Net Profit)
(*All values are in Rs. Cr)
Consolidated Financial Performace In Graph(Net Profit)
Standalone Financial Performace In Graph(Net Profit)
(*All values are in Rs. Cr)
Consolidated Financial Performace In Graph(Cash Flow)
Standalone Financial Performace In Graph(Cash Flow)
Pros
Momentum Strength
Zero Debt
Above Average Growth Rate
Cons
Low Sustainable RoE
Low Return on Capital Employed
Poor Cash Flow Conversion
Negative operating earnings and interest coverage
Highly Cyclical Industry
Low Pricing Power & High Competition
Capital Intensive Business
Poor Working Capital Cycle
Negative Margin of Safety
Valuation Analysis
Margin of safety
(10/09/2024)
(10/09/2024)
80
37.50%
37.50% People are bullish about Panacea Biotec Ltd
62.50%
62.50 % People are bearish about Panacea Biotec Ltd